Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 610

1.
3.

Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast.

Solin LJ, Recht A, Fourquet A, Kurtz J, Kuske R, McNeese M, McCormick B, Cross MA, Schultz DJ, Bornstein BA, et al.

Cancer. 1991 Dec 1;68(11):2337-44.

4.

Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.

Hwang N, Schiller DE, Crystal P, Maki E, McCready DR.

Ann Surg Oncol. 2009 Nov;16(11):3000-9. doi: 10.1245/s10434-009-0607-1. Epub 2009 Jul 15.

PMID:
19603233
5.

Long-term results of local recurrence after breast conservation treatment for invasive breast cancer.

Doyle T, Schultz DJ, Peters C, Harris E, Solin LJ.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):74-80.

PMID:
11516854
6.

Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.

Al-Hallaq HA, Mell LK, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, Newstead GM, Chmura SJ.

Cancer. 2008 Nov 1;113(9):2408-14. doi: 10.1002/cncr.23872.

7.

Outcomes after breast conservation treatment with radiation in women with prior nonbreast malignancy and subsequent invasive breast carcinoma.

Nemani D, Vapiwala N, Hwang WT, Solin LJ.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1055-60. doi: 10.1016/j.ijrobp.2008.05.049. Epub 2008 Oct 17.

PMID:
18929447
8.

Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast.

Harris EE, Schultz DJ, Peters CA, Solin LJ.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):933-41.

PMID:
11072148
9.

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8. doi: 10.1111/j.1445-2197.2007.04354.x.

PMID:
18199204
10.

An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience.

Haas JA, Schultz DJ, Peterson ME, Solin LJ.

Cancer J Sci Am. 1998 Sep-Oct;4(5):308-15.

PMID:
9815295
11.

Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma.

Solin LJ, Hwang WT, Vapiwala N.

Clin Breast Cancer. 2009 May;9(2):96-100. doi: 10.3816/CBC.2009.n.018.

PMID:
19433390
12.

Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.

Solin LJ, Fourquet A, McCormick B, Haffty B, Recht A, Schultz DJ, Barrett W, Fowble BL, Kuske R, Taylor M, et al.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):3-9.

PMID:
8083125
13.

Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?

Yerushalmi R, Sulkes A, Mishaeli M, Neumann A, Dinerman M, Sulkes J, Rizel S, Yarom N, Gutman H, Fenig E.

Neoplasma. 2006;53(6):507-10.

PMID:
17167720
14.

Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.

Solin LJ, Yeh IT, Kurtz J, Fourquet A, Recht A, Kuske R, McCormick B, Cross MA, Schultz DJ, Amalric R, et al.

Cancer. 1993 Apr 15;71(8):2532-42.

15.

Wide local excision and radiotherapy for the treatment of ductal carcinoma in situ of the breast: the Hong Kong experience.

Yau TK, Chan K, Chant M, Lau HW, Soong IS, Cheung P, Chang AT, Lee AW.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):447-52.

PMID:
16909967
16.

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.

Hartman AR, Daniel BL, Kurian AW, Mills MA, Nowels KW, Dirbas FM, Kingham KE, Chun NM, Herfkens RJ, Ford JM, Plevritis SK.

Cancer. 2004 Feb 1;100(3):479-89.

17.

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.

Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Lemanski C, Auvray H, Jacquot S, Charpentier JC.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):868-79.

PMID:
12095552
18.

Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.

Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK.

Am J Surg. 2006 Oct;192(4):552-5.

PMID:
16978974
19.

Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience.

Santiago RJ, Wu L, Harris E, Fox K, Schultz D, Glick J, Solin LJ.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):233-40.

PMID:
14697443
20.

Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.

Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ.

Ann Surg Oncol. 2005 Dec;12(12):1045-53. Epub 2005 Oct 25.

PMID:
16244803

Supplemental Content

Support Center